Perform Another (Advanced) Search

1.  Study Posting (4959) Trial #159789, Hypertension (High Blood Pressure), New York, NY
...York, NY Trial Information Nebivolol vs. Metoprolol: Comparative Effects of Fatigue and Quality of Life Beta-blockers are used widely to treat hypertension, but cause fatigue in a substantial number of people ...
View Page

2.  Study Posting (2348) Trial #121280, Heart Defect, New York, NY
...Study Posting (2348) Trial #121280, Heart Defect, New York, NY Trial Information Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals with Marfan Syndrome The ...
View Page

3.  Study Posting (1819) Trial #136315, Cardiovascular Abnormalities, Cincinnati, OH
...Study What is the purpose of this study? This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of ...
View Page

4.  CenterWatch: Clinical Trials in Category (644) Heart Defect
...X]   Switzerland • [X]   United Kingdom New York New York : Mount Sinai Medical Center Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals with Marfan Syndrome Canada ...
View Page

5.  Newly Approved Drug Therapies (1025) Toprol-XL (metoprolol succinate), AstraZeneca,
...release of metoprolol for once-daily administration. Hypertension The mechanism of the antihypertensive effects of beta-blocking agents is not fully known. However, several possible mechanisms have been proposed: (1) competitive antagonism ...
View Page

6.  Study Posting (5194) Trial #157673, Hypertension (High Blood Pressure), Walnut Creek, CA
...significant respiratory, liver, or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

7.  Study Posting (5306) Trial #158870, Hypertension (High Blood Pressure), Santa Ana, CA
...significant respiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

8.  Study Posting (5306) Trial #158871, Hypertension (High Blood Pressure), Riverside, CA
...significant respiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

9.  Study Posting (5306) Trial #158872, Hypertension (High Blood Pressure), Costa Mesa, CA
...significant respiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

10. Clinical Trial Results by Drug Names
...Men and women >18 years with heart failure of any etiology, no established treatment with beta-blockers and with an ability to participate in an outpatient cardiac rehabilitation program. Test product, dose ...
View Page

11.  Study Posting (4120) Trial #160020, Hypertension (High Blood Pressure), Huntsville, AL
...significant resiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

12.  Study Posting (5206) Trial #158712, Hypertension (High Blood Pressure), Riverside, CA
...significant respiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

13.  Study Posting (5206) Trial #158713, Hypertension (High Blood Pressure), Costa Mesa, CA
...significant respiratory, liver or cardiovascular disease • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates • Have a history of hypersensitivity to nebivolol, other beta-blockers ...
View Page

14. Clinical Trial Results by Drug Names
...of patients), >75–80 years (31%), and >80 years (29%). Impact of co-morbidities where beta-blockers are relatively contraindicated (eg, obstructive airway disease [OAD; 12% of patients] and presence of diabetes ...
View Page

15.  Study Posting (1570) Trial #156490, Heart Failure, Morristown, NJ
...failure (such as diuretic, angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) and beta blocker) for at least three months prior to the baseline evaluation. • Subject has been on stable ...
View Page

16.  Study Posting (3337) Trial #121394, Parkinson's Disease, Sun City, AZ
...five years • 30 years and older • Anti-Parkinson treatment with anti-cholinergics, MAO inhibitors, and beta blockers allowed if there has been a stable dose for at least four weeks • Modified Hoehn ...
View Page

17.  Newly Approved Drug Therapies (429) Cosopt, Merck,
...in patients with open-angle glaucoma or ocular hypertension who do not respond adequately to beta-blockers alone. Both components of Cosopt are leading therapies in their product categories and are currently ...
View Page

18.  Newly Approved Drug Therapies (334) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan,
...daily starting 24 hours after surgery for two weeks. It can be used with antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. For itch, Acular is administered between one and four ...
View Page

19.  Study Posting (4519) Trial #105262, Heart Failure, Bern, Switzerland
...adult patients >18 years of age; • heart failure of any etiology; • no established treatment with beta-blockers. Exclusion Criteria: • planned coronary bypass surgery or coronary angioplasty in the next 12 weeks; • contraindication ...
View Page

20.  Newly Approved Drug Therapies (593) Niaspan, Kos Pharmaceuticals,
...HDL cholesterol include: • Obesity • Low total, high polyunsaturated fat diet • Cigarette smoking • Thiazide diuretics • Some beta-blockers • Probucol • Anabolic steroids • Liver or kidney failure • Hyperthyroidism • Some forms of diabetes • Acute inflammation/injury ...
View Page